×
Phreesia Operating Expenses 2019-2025 | PHR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Phreesia operating expenses from 2019 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
View More
Phreesia Operating Expenses 2019-2025 | PHR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Phreesia operating expenses from 2019 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$46.6B
Tempus AI (TEM)
$13.2B
Doximity (DOCS)
$12.4B
Hims & Hers Health (HIMS)
$9.7B
IRhythm Technologies (IRTC)
$5.3B
Hinge Health (HNGE)
$4.3B
Inspire Medical Systems (INSP)
$2.7B
Privia Health (PRVA)
$2.6B
Heartflow (HTFL)
$2.4B
Enovis (ENOV)
$1.8B
10x Genomics (TXG)
$1.8B
Omnicell (OMCL)
$1.5B
Schrodinger (SDGR)
$1.4B
Azenta (AZTA)
$1.4B
Clover Health Investments (CLOV)
$1.4B
Claritev (CTEV)
$1.2B
Evolent Health (EVH)
$1.1B
Fulgent Genetics (FLGT)
$659M
Zepp Health (ZEPP)
$570M
Veradigm (MDRX)
$525M
Standard BioTools (LAB)
$474M
Talkspace (TALK)
$445M
Butterfly Network (BFLY)
$390M
Carlsmed (CARL)
$380M
TruBridge (TBRG)
$298M
Outset Medical (OM)
$244M
Health Catalyst (HCAT)
$235M
SOPHiA GENETICS SA (SOPH)
$233M
Nyxoah SA (NYXH)
$220M
KORU Medical Systems (KRMD)
$194M